147 related articles for article (PubMed ID: 31611980)
1. STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.
Osone K; Yokobori T; Katayama C; Takahashi R; Kato R; Tatsuski H; Takada T; Yajima R; Motegi Y; Ogawa H; Fujii T; Ojima H; Nakamura J; Yao T; Shirabe K; Kuwano H
Oncol Lett; 2019 Nov; 18(5):4712-4718. PubMed ID: 31611980
[TBL] [Abstract][Full Text] [Related]
2. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
[TBL] [Abstract][Full Text] [Related]
3. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
[TBL] [Abstract][Full Text] [Related]
5. Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
Merli AM; Vieujean S; Massot C; Blétard N; Quesada Calvo F; Baiwir D; Mazzucchelli G; Servais L; Wéra O; Oury C; de Leval L; Sempoux C; Manzini R; Bluemel S; Scharl M; Rogler G; De Pauw E; Coimbra Marques C; Colard A; Vijverman A; Delvenne P; Louis E; Meuwis MA
J Crohns Colitis; 2020 Sep; ():. PubMed ID: 32920643
[TBL] [Abstract][Full Text] [Related]
6. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
7. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia.
Orita F; Ishikawa T; Ishiguro M; Okazaki S; Kikuchi A; Yamauchi S; Matsuyama T; Tokunaga M; Uetake H; Kinugasa Y
Mol Clin Oncol; 2021 Sep; 15(3):192. PubMed ID: 34349991
[TBL] [Abstract][Full Text] [Related]
8. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
9. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.
Ozawa N; Yokobori T; Osone K; Katayama C; Suga K; Komine C; Shibasaki Y; Shiraishi T; Okada T; Kato R; Ogawa H; Sano A; Sakai M; Sohda M; Ojima H; Miyazaki T; Motegi Y; Ide M; Yao T; Kuwano H; Shirabe K; Saeki H
Sci Rep; 2021 Jun; 11(1):13077. PubMed ID: 34158547
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
Maruyama K; Saigusa N; Baba S; Kino I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
[TBL] [Abstract][Full Text] [Related]
13. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
[TBL] [Abstract][Full Text] [Related]
14. Use of segmental colorectal lavage cytology during surveillance colonoscopy for detecting dysplastic and cancer cells in patients with ulcerative colitis.
Torii Y; Sano D; Ikeuchi H; Hida N; Hirota S
Int J Clin Exp Pathol; 2020; 13(8):2035-2040. PubMed ID: 32922598
[TBL] [Abstract][Full Text] [Related]
15. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
[TBL] [Abstract][Full Text] [Related]
16. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.
May D; Pan S; Crispin DA; Lai K; Bronner MP; Hogan J; Hockenbery DM; McIntosh M; Brentnall TA; Chen R
J Proteome Res; 2011 Jan; 10(1):200-9. PubMed ID: 20828217
[TBL] [Abstract][Full Text] [Related]
17. HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
Okami H; Ozawa N; Sohda M; Yokobori T; Osone K; Erkhem-Ochir B; Dorjkhorloo G; Shiraishi T; Okada T; Sano A; Sakai M; Miyazaki T; Ogawa H; Yao T; Oike T; Sato H; Shirabe K; Shibata A; Saeki H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686454
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation in patients with ulcerative colitis in rectal biopsy.
Kim HJ; Chang SK
Korean J Intern Med; 1998 Jul; 13(2):110-6. PubMed ID: 9735666
[TBL] [Abstract][Full Text] [Related]
19. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.
Chen R; Rabinovitch PS; Crispin DA; Emond MJ; Koprowicz KM; Bronner MP; Brentnall TA
Am J Pathol; 2003 Feb; 162(2):665-72. PubMed ID: 12547724
[TBL] [Abstract][Full Text] [Related]
20. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
